Nkgen Biotech Inc (NKGN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.1355 -0.0150 (-9.97%) 04/25/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.1355 unch (unch) 15:56 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -82,954 | -26,754 | -991 | N/A | N/A |
| Depreciation Amortization | 1,203 | 1,210 | N/A | N/A | N/A |
| Accounts receivable | 29 | -29 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,993 | 443 | 52 | N/A | N/A |
| Other Working Capital | 2,226 | 30 | 982 | N/A | N/A |
| Other Operating Activity | 53,555 | 2,543 | -1,566 | 0 | 0 |
| Operating Cash Flow | $-21,948 | $-22,557 | $-1,524 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48 | -163 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -171,615 | N/A | N/A |
| Investing Cash Flow | $-48 | $-163 | $-171,615 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 26,506 | 23,000 | 1 | N/A | N/A |
| Debt Repayment | -300 | N/A | -70 | N/A | N/A |
| Common Stock Issued | 11,890 | 161 | N/A | N/A | N/A |
| Other Financing Activity | -15,941 | -675 | 174,931 | 0 | 0 |
| Financing Cash Flow | $22,155 | $22,486 | $174,861 | $N/A | $N/A |
| Beginning Cash Position | 117 | 351 | N/A | N/A | N/A |
| End Cash Position | 276 | 117 | 1,723 | N/A | N/A |
| Net Cash Flow | $159 | $-234 | $1,723 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,948 | -22,557 | -1,524 | N/A | N/A |
| Capital Expenditure | -48 | -163 | N/A | N/A | N/A |
| Free Cash Flow | -21,996 | -22,720 | -1,524 | 0 | 0 |